Sir,
Topically applied ophthalmic medications may sometimes get absorbed into the systemic circulation and lead to significant toxicity. We, herein, report a case of systemic toxicity of topical cyclopentolate eyedrops in a young child.
Case report
A 5-year-old boy presented to paediatric OPD with complaint of progressively diminishing distant vision since 2 years of age. He had normal general physical and systemic examination. Ocular movements and light and accommodation reflexes were bilaterally normal. For fundus examination, he was advised to instill 1% cyclopentolate eyedrops, two drops in each eye, three times at 15 min intervals. However, the father inadvertently instilled it five to six times over 2 h. After another 1 h, he reported again to our OPD with altered behaviour, visual hallucinations, and difficulty in walking. He was disoriented, with ataxic gait and slurred speech. Pupils were widely dilated and fixed (effect of cyclopentolate). Rest of the examination was unremarkable.
Based on these findings and their temporal relation to overdose of cyclopentolate eyedrops, a diagnosis of cyclopentolate toxicity was made. His symptoms gradually resolved over the next 6–8 h. He was discharged after 24 h of observation.
Comment
Cyclopentolate is a synthetic anticholinergic agent and causes rapid-onset cycloplegia.1 Onset is within 30–60 min and effects last up to a day.2 Cyclopentolate eyedrops pass readily through nasolacrimal duct and are well absorbed locally as well as systemically through conjunctiva and nasal mucosa. Systemic absorption also occurs through oropharynx, digestive system, and skin.3, 4
There have been various reports of systemic toxicity following topical application of cyclopentolate eyedrops.3, 4, 5, 6, 7 Children are especially prone due to lower body weight. Various manifestations in children include flushing, tachycardia, feeding intolerance, seizures, and drowsiness. Behavioural changes and transient psychotic reactions may also occur.7 Physostigmine is the antidote of choice as it readily crosses the blood–brain barrier. Commonly used anticholinesterases such as neostigmine, pyridostigmine, and edrophonium do not cross the blood–brain barrier, and are not useful.8 We could not use physostigmine due to non-availability.
This case highlights the importance of caution to be exercised while using topical ophthalmic preparations in children. Physicians should be well aware of their pharmacology and use them judiciously.
References
Gray C . Systemic toxicity with topical ophthalmic medications in children. Paed Perinat Drug Ther 2006; 7: 23–29.
Pappano AJ, Katzung BG . Cholinoceptor-blocking drugs. In: Katzung B, (ed.), Basic and Clinical Pharmacology 9th edn. The McGraw-Hill Companies Inc: NY, USA, 2004, pp 109–121.
Lim DL, Batilando M, Rajadurai VS . Transient paralytic ileus following the use of cyclopentolate-phenylephrine eye drops during screening for retinopathy of prematurity. J Paediatr Child Health 2003; 39: 318–320.
Mirshahi A, Kohnen T . Acute psychotic reaction caused by topical cyclopentolate use for cycloplegic refraction before refractive surgery: case report and review of the literature. J Cataract Refract Surg 2003; 29: 1026–1030.
Demayo AP, Reidenberg MM . Grand mal seizure in a child 30 minutes after Cyclogyl (cyclopentolate hydrochloride) and 10% Neo-Synephrine (phenylephrine hydrochloride) eye drops were instilled. Pediatrics 2004; 113: e499–e500.
Mirshahi A, Kohnen T . Acute psychotic reaction caused by topical cyclopentolate use for cycloplegic refraction before refractive surgery: case report and review of the literature. J Cataract Refract Surg 2003; 29: 1026–1030.
Bhatia SS, Vidyashankar C, Sharma RK, Dubey AK . Systemic toxicity with cyclopentolate eye drops. Indian Pediatr 2000; 37: 329–331.
Brown DV, Heller F, Barkin R . Anticholinergic syndrome after anesthesia: a case report and review. Am J Ther 2004; 11: 144–153.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Pooniya, V., Pandey, N. Systemic toxicity of topical cyclopentolate eyedrops in a child. Eye 26, 1391–1392 (2012). https://doi.org/10.1038/eye.2012.149
Published:
Issue Date:
DOI: https://doi.org/10.1038/eye.2012.149
This article is cited by
-
Incidence of side effects of topical atropine sulfate and cyclopentolate hydrochloride for cycloplegia in Japanese children: a multicenter study
Japanese Journal of Ophthalmology (2018)
-
Routine use of topical cyclopentolate as a predisposing factor to recurrent urinary tract infections in a susceptible adult
Eye (2013)
-
Cyclopentolate overdose
Reactions Weekly (2012)